NCT02324608View on ClinicalTrials.gov

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 30, 2015

Primary Completion Date

December 9, 2020

Study Completion Date

May 30, 2023

Conditions
Recurrent Skin CancerSquamous Cell Carcinoma of the Skin
Interventions
BIOLOGICAL

cetuximab

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Rutgers Cancer Institute of New Jersey

OTHER

lead

Rutgers, The State University of New Jersey

OTHER

NCT02324608 - Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | Biotech Hunter | Biotech Hunter